tirzepatide health canada approval approves Mounjaro® (tirzepatide) for use in children 10 years and older living with type 2 diabetes Weight-loss drug approved to treat

For people who do not meet the BMI threshold for GLP-1 medication prescriptions but still want metabolic support, a probiotic approach offers a lower-barrier option

Notice: The above information is an educational aid only

The platform coordinates the process but does not manufacture, dispense, or control the formulation of any medications prescribed as part of these services

Cavallari, I

Press release: Novo Nordisk presents four new analyses on oral semaglutide 25 mg (Wegovy in a pill ) at ObesityWeek 2025, including demonstrated reductions in cardiovascular risk factors.* Retrieved from Rosenstock, J., Hsia, S., Ruiz, L